Lv1
80 积分 2022-09-14 加入
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
3天前
已完结
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial
3天前
已完结
Menin inhibitors for patients with relapsed/refractory acute myeloid leukemia (AML): a systematic review and meta-analysis
8天前
已完结
The Care and Cure of the Leukemias in 2026
8天前
已完结
Measurable residual disease intervention in AML: a new therapeutic horizon
8天前
已完结
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
9天前
已完结
Epcoritamab in B-cell malignancies: current status and prospects
1个月前
已完结
The future of follicular lymphoma management: strategies on the horizon
1个月前
已完结
皖公网安备34019202002308
